KIORA PHARMACEUTICALS CEO Brian Strem's 2023 pay rises 12% to $802K
KIORA PHARMACEUTICALS reports 2023 executive compensation
By ExecPay News
Published: March 25, 2024
KIORA PHARMACEUTICALS reported fiscal year 2023 executive compensation information on March 25, 2024.
In 2023, three executives at KIORA PHARMACEUTICALS received on average a compensation package of $614K, a 58% increase compared to previous year.
Average pay of disclosed executives at KIORA PHARMACEUTICALS
Brian M. Strem, Chief Executive Officer, received $802K in total, which increased by 12% compared to 2022. 52% of Strem's compensation, or $416K, was in salary. Strem also received $170K in bonus, $114K in option awards, as well as $102K in stock awards.
Eric J. Daniels, Chief Development Officer, received a compensation package of $652K, which increased by 19% compared to previous year. 52% of the compensation package, or $339K, was in salary.
Melissa Tosca, Executive Vice President of Finance, earned $387K in 2023, a 192% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 25, 2024.